The prognostic role of PIK3CA mutations in breast cancer is equivocal, however a meta-analysis performed on PIK3CA mutation status in human breast cancer showed that mutations in this gene represented an independent negative prognostic factor with a hazard ratio of 1.6737. This evidence concerns the gene PIK3CA and breast carcinoma.